Miracle Mile Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.51M Buy
392,395
+7,243
+2% +$175K 0.11% 139
2026
Q1
$9.34M Buy
385,152
+242,571
+170% +$5.88M 0.13% 125
2025
Q4
$3.45M Sell
142,581
-72
-0.1% -$1.75K 0.05% 233
2025
Q3
$3.47M Buy
+142,653
New +$3.45M 0.05% 224
2024
Q2
Sell
-29,659
Closed -$707K 517
2024
Q1
$707K Sell
29,659
-2,800
-9% -$66.8K 0.02% 306
2023
Q4
$776K Hold
32,459
0.02% 288
2023
Q3
$757K Sell
32,459
-10,277
-24% -$241K 0.02% 282
2023
Q2
$1M Sell
42,736
-3,699
-8% -$87.4K 0.03% 259
2023
Q1
$1.1M Sell
46,435
-894,504
-95% -$21.1M 0.04% 261
2022
Q4
$22M Buy
+940,939
New +$21.8M 0.75% 35

Other funds holding IBDR

Miracle Mile Advisors's IBDR Position: Q2 2026 in Review

Miracle Mile Advisors increased its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 1.9% in Q2 2026, buying an estimated $175K and bringing the position to 392,395 shares worth $9.51M. The position accounts for 0.11% of the portfolio, ranked #139.

Miracle Mile Advisors first reported a position in IBDR in Q4 2022 and has held it in 10 quarters since. The position peaked at $22M in Q4 2022. 422 funds tracked by Wall St. Rank hold IBDR as of Q2 2026.

  • Miracle Mile Advisors held 392,395 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $9.51M as of Q2 2026.
  • Miracle Mile Advisors bought 7,243 iShares iBonds Dec 2026 Term Corporate ETF shares in Q2 2026, an estimated $175K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.11% of Miracle Mile Advisors's portfolio in Q2 2026, its #139 holding.
  • Miracle Mile Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q4 2022 and has held it in 10 quarters since.
  • Miracle Mile Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $22M in Q4 2022.
  • 422 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.